tiprankstipranks
Advertisement
Advertisement
Mesoblast rises 6.2%
PremiumThe FlyMesoblast rises 6.2%
20d ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
Mesoblast receives BLA filing number from FDA for rexlemestrocel-L review
Premium
The Fly
Mesoblast receives BLA filing number from FDA for rexlemestrocel-L review
1M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
4M ago
Mesoblast acquires chimeric antigen receptor platform technology
Premium
The Fly
Mesoblast acquires chimeric antigen receptor platform technology
4M ago
Mesoblast receives IND clearance from FDA for Ryoncil trial
Premium
The Fly
Mesoblast receives IND clearance from FDA for Ryoncil trial
4M ago
Mesoblast Discloses Director Gregory George’s Share and ADS Purchases in Early March 2026
PremiumCompany AnnouncementsMesoblast Discloses Director Gregory George’s Share and ADS Purchases in Early March 2026
5M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
5M ago
Mesoblast Earnings Call: Ryoncil Momentum Meets Rising Costs
Premium
Company Announcements
Mesoblast Earnings Call: Ryoncil Momentum Meets Rising Costs
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100